Event

MDMC Annual Conference 2023

Time -

The Medical Device Manufacturing Centre (MDMC) is hosting its 2nd Annual Conference which will bring together industry, NHS and academia to discuss the latest services offered by stakeholders in the life sciences and healthcare sector.

This conference is unique in its breadth and offers the opportunity for delegates to find out more about initiatives set by the NHS and government, as well as learn about the latest advances by companies in the sector.

It will provide invaluable networking opportunities and companies will be offered free exhibition space on a first come, first served basis. Academia will have the opportunity to present their research work through a posters exhibition.

If you are interested in the latest MedTech news and tips, or seek further insight into growing your business, come along and be a part of this invaluable opportunity to network with like-minded individuals, companies and stakeholders in the Scottish life sciences and healthcare sector.

Programme:

The morning session focus is on the services that SMEs can access to accelerate innovation.

The afternoon session will explore the activities and services in health and care offered by organisations such as Scottish Enterprise, the Centre for Process Innovations (CPI), and the Digital Health and Care Innovation Centre (DHI-Scotland).

About MDMC

The mission of the MDMC is to provide expert advice on manufacturing engineering, regulatory issues and funding, coupled with technically supported access to manufacturing facilities, to assist small- and medium-sized companies in the translation of medical device concepts through to small batch commercial prototypes. Services provided by the MDMC are free of charge to SMEs, with priority to Scottish SMEs at all times.

A consortium of 4 universities led by Heriot-Watt and funded from the Advancing Manufacturing Challenge Fund (AMCF) and the Edinburgh City Deal, the MDMC offers medical device development and manufacture in Scotland, providing companies with an enabling step towards first-in-patient-studies.